Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 12.

Lindlau, A; Widmann, C N; Putensen, C; Jessen, F; Semmler, A; Heneka, M T (2015). Predictors of hippocampal atrophy in critically ill patients. European Journal of Neurology, 22(2):410-415.

Bosch, O G; Wagner, M; Jessen, F; Kühn, K U; Joe, A; Seifritz, E; Maier, W; Biersack, H J; Quednow, Boris B (2013). Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users. PLoS ONE, 8(4):e61234.

Semmler, A; Widmann, C N; Okulla, T; Urbach, H; Kaiser, M; Widman, G; Mormann, F; Weide, J; Fliessbach, K; Hoeft, A; Jessen, F; Putensen, C; Heneka, M T (2013). Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. Journal of Neurology, Neurosurgery, and Psychiatry, 84(1):62-69.

Smith, D E C; Smulders, Y M; Blom, H J; Popp, J; Jessen, F; Semmler, A; Farkas, M; Linnebank, M (2012). Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid. Clinical Chemistry and Laboratory Medicine, 50(9):1641-1647.

Arlt, S; Schwedhelm, E; Kölsch, H; Jahn, H; Linnebank, M; Smulders, Y; Jessen, F; Böger, R H; Popp, J (2012). Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease. Journal of Alzheimer's Disease, 31(4):751-758.

Papassotiropoulos, A; Henke, K; Stefanova, E; Aerni, A; Müller, A; Demougin, P; Vogler, C; Sigmund, J C; Gschwind, L; Huynh, K D; Coluccia, D; Mondadori, C R; Hänggi, J; Buchmann, A; Kostic, V; Novakovic, I; van den Bussche, H; Kaduszkiewicz, H; Weyerer, S; Bickel, H; Riedel-Heller, S; Pentzek, M; Wiese, B; Dichgans, M; Wagner, M; Jessen, F; Maier, W; de Quervain, D J F (2011). A genome-wide survey of human short-term memory. Molecular Psychiatry, 16(2):184-192.

Linnebank, M; Popp, J; Smulders, Y; Smith, D; Semmler, A; Farkas, M; Kulic, L; Cvetanovska, G; Blom, H; Stoffel-Wagner, B; Kölsch, H; Weller, M; Jessen, F (2010). S-Adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegenerative Diseases, 7(6):373-378.

Striepens, N; Scheef, L; Wind, A; Popp, J; Spottke, A; Cooper-Mahkorn, D; Suliman, H; Wagner, M; Schild, H H; Jessen, F (2010). Volume loss of the medial temporal lobe structures in subjective memory impairment. Dementia and Geriatric Cognitive Disorders, 29(1):75-81.

Popp, J; Lewczuk, P; Linnebank, M; Cvetanovska, G; Smulders, Y; Kölsch, H; Frommann, I; Kornhuber, J; Maier, W; Jessen, F (2009). Homocysteine metabolism and CSF markers for Alzheimer's disease. Journal of Alzheimer's Disease, 5(4 / Su):500.

Jessen, F; Schuhmacher, A; von Widdern, O; Guttenthaler, V; Hofels, S; Suliman, H; Scheef, L; Block, W; Urbach, H; Maier, W; Zobel, A (2009). No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression. Psychiatric Genetics, 19(2):99-101.

Pearson, J V; Huentelman, M J; Halperin, R F; Tembe, W D; Melquist, S; Homer, N; Brun, M; Szelinger, S; Coon, K D; Zismann, V L; Webster, J A; Beach, T; Sando, S B; Aasly, J O; Heun, R; Jessen, F; Kölsch, H; Tsolaki, M; Daniilidou, M; Reiman, E M; Papassotiropoulos, A; Hutton, M L; Stephan, D A; Craig, D W (2007). Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. American Journal of Human Genetics, 80(1):126-139.

Bagli, M; Papassotiropoulos, A; Hampel, H; Becker, K; Jessen, F; Bürger, K; Ptok, U; Rao, M L; Möller, H J; Maier, W; Heun, R (2003). Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study. European Archives of Psychiatry and Clinical Neuroscience, 253(1):44-48.

This list was generated on Sat Nov 18 00:23:04 2017 CET.